Cargando…
Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis
Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have prop...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856204/ https://www.ncbi.nlm.nih.gov/pubmed/36672661 http://dx.doi.org/10.3390/biomedicines11010152 |
_version_ | 1784873566345363456 |
---|---|
author | Takemoto, Yuki Matsuzaki, Shinya Matsuzaki, Satoko Kakuda, Mamoru Lee, Misooja Hayashida, Harue Maeda, Michihide Kamiura, Shoji |
author_facet | Takemoto, Yuki Matsuzaki, Shinya Matsuzaki, Satoko Kakuda, Mamoru Lee, Misooja Hayashida, Harue Maeda, Michihide Kamiura, Shoji |
author_sort | Takemoto, Yuki |
collection | PubMed |
description | Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have proposed a type III classification. This study aimed to review the current evidence on type III vasa previa. A systematic literature search was conducted, and 11 articles (2011–2022) were included. A systematic review showed that type III vasa previa accounts for 5.7% of vasa previa cases. Thirteen women with type III vasa previa were examined at a patient-level analysis. The median age was 35 (interquartile range [IQR] 31.5–38) years, and approximately 45% were assisted reproductive technology (ART) pregnancies. The median gestational week of delivery was 36 (IQR 34–37) weeks; the antenatal detection rate was 84.6%, and no cases reported neonatal death. The characteristics and obstetric outcomes (rate of ART, antenatal diagnosis, emergent cesarean delivery, gestational age at delivery, and neonatal mortality) were compared between types I and III vasa previa, and all outcomes of interest were similar. The current evidence on type III vasa previa is scanty, and further studies are warranted. |
format | Online Article Text |
id | pubmed-9856204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98562042023-01-21 Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis Takemoto, Yuki Matsuzaki, Shinya Matsuzaki, Satoko Kakuda, Mamoru Lee, Misooja Hayashida, Harue Maeda, Michihide Kamiura, Shoji Biomedicines Systematic Review Vasa previa carries a high risk of severe fetal morbidity and mortality due to fetal hemorrhage caused by damage to unprotected fetal cord vessels upon membrane rupture. Vasa previa is generally classified into types I and II. However, some cases are difficult to classify, and some studies have proposed a type III classification. This study aimed to review the current evidence on type III vasa previa. A systematic literature search was conducted, and 11 articles (2011–2022) were included. A systematic review showed that type III vasa previa accounts for 5.7% of vasa previa cases. Thirteen women with type III vasa previa were examined at a patient-level analysis. The median age was 35 (interquartile range [IQR] 31.5–38) years, and approximately 45% were assisted reproductive technology (ART) pregnancies. The median gestational week of delivery was 36 (IQR 34–37) weeks; the antenatal detection rate was 84.6%, and no cases reported neonatal death. The characteristics and obstetric outcomes (rate of ART, antenatal diagnosis, emergent cesarean delivery, gestational age at delivery, and neonatal mortality) were compared between types I and III vasa previa, and all outcomes of interest were similar. The current evidence on type III vasa previa is scanty, and further studies are warranted. MDPI 2023-01-07 /pmc/articles/PMC9856204/ /pubmed/36672661 http://dx.doi.org/10.3390/biomedicines11010152 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Takemoto, Yuki Matsuzaki, Shinya Matsuzaki, Satoko Kakuda, Mamoru Lee, Misooja Hayashida, Harue Maeda, Michihide Kamiura, Shoji Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title | Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title_full | Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title_fullStr | Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title_full_unstemmed | Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title_short | Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis |
title_sort | current evidence on vasa previa without velamentous cord insertion or placental morphological anomalies (type iii vasa previa): systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856204/ https://www.ncbi.nlm.nih.gov/pubmed/36672661 http://dx.doi.org/10.3390/biomedicines11010152 |
work_keys_str_mv | AT takemotoyuki currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT matsuzakishinya currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT matsuzakisatoko currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT kakudamamoru currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT leemisooja currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT hayashidaharue currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT maedamichihide currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis AT kamiurashoji currentevidenceonvasapreviawithoutvelamentouscordinsertionorplacentalmorphologicalanomaliestypeiiivasapreviasystematicreviewandmetaanalysis |